|
Volumn 37, Issue 9, 2005, Pages 3963-3964
|
Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
LAMIVUDINE;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
RNA;
STEROID;
TACROLIMUS;
ADULT;
AGE DISTRIBUTION;
ARTERY THROMBOSIS;
ARTIFICIAL EMBOLISM;
CAUSE OF DEATH;
CHOLANGITIS;
CHRONIC HEPATITIS;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CONFERENCE PAPER;
CONTROLLED STUDY;
DEVICE;
DRUG HYPERSENSITIVITY;
FEMALE;
FIBROSIS;
GENOTYPE;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HISTOPATHOLOGY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
LIVER BIOPSY;
LIVER TRANSPLANTATION;
MALE;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
QUALITATIVE ANALYSIS;
QUANTITATIVE ANALYSIS;
RECURRENT INFECTION;
SEX DIFFERENCE;
SPLEEN;
VIRAL GENETICS;
ADULT;
ANTIVIRAL AGENTS;
BIOPSY;
FEMALE;
HEPATITIS B;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
LAMIVUDINE;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
RECURRENCE;
RIBAVIRIN;
TREATMENT OUTCOME;
|
EID: 29544446176
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.10.060 Document Type: Conference Paper |
Times cited : (23)
|
References (7)
|